Think About The Supply Chain And Manufacturability Before Asset Acquisition

Source: Life Science Leader

In this executive virtual roundtable (EVR) segment, Louise Perry, SVP Tech Ops, Solid Biosciences, discusses the importance of executives thinking through various supply chain issues before acquiring an asset. Joining the conversation are Bryan Butman, Ph.D., head of CMC, Precigen; and Tim Valko, head of global manufacturing supply chain, Atara Biotherapeutics.